Stay updated on M-001 Safety/Immunogenicity as Standalone & H5N1 Primer Clinical Trial

Sign up to get notified when there's something new on the M-001 Safety/Immunogenicity as Standalone & H5N1 Primer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the M-001 Safety/Immunogenicity as Standalone & H5N1 Primer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page content remains unchanged based on the provided change data.
    Difference
    0.1%
    Check dated 2026-05-22T18:52:27.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.3 to v3.5.4, signaling a minor patch or update to the page's documentation.
    Difference
    0.1%
    Check dated 2026-05-15T15:15:59.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page’s footer has been updated from Revision v3.5.2 to Revision v3.5.3, indicating a minor technical/version update rather than a change to the study information.
    Difference
    0.1%
    Check dated 2026-04-24T06:13:39.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:43:45.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Added a new site revision note (v3.5.0) and removed the previous revision note (v3.4.3).
    Difference
    0.1%
    Check dated 2026-03-19T05:25:30.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-12T02:17:42.000Z thumbnail image

Stay in the know with updates to M-001 Safety/Immunogenicity as Standalone & H5N1 Primer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the M-001 Safety/Immunogenicity as Standalone & H5N1 Primer Clinical Trial page.